Uncovering Proteomic Biomarkers Linking Type 2 Diabetes to Cardiovascular Risk
Date: Apr 16, 2025
Cardiovascular expert Prof. Karol Kaminski, MD, PhD, presents a study that identified proteomic biomarkers in individuals with untreated glucose metabolism disturbances who are not diagnosed with diabetes, chronic inflammatory, neoplastic, or cardiovascular disease.
Product insightsBeyond Genomics: A Conversation with Thought Leaders on NGS-Based Proteomics
Join our conversation with global thought leaders as they unpack the latest trends, breakthroughs, and future directions in NGS-based proteomics.
15 May 2025
- Product insights
A Complete Solution for Identifying Protein Signatures: From Sample to Actionable Results
Explore how the Olink® Signature Q100 benchtop system and NPX Signature software are part of a complete solution for generating meaningful protein signatures, from study design to data interpretation.
03 Apr 2025
- Product insights
Affinity Proteomics and LC-MS synergize Biomarker Discovery
Olink Certified Service Provider, Discovery Life Sciences, compares cutting-edge technology to study the proteome in liquid matrices.
15 Jan 2025